Stock Price
16.49
Daily Change
-1.03 -5.88%
Monthly
-8.54%
Yearly
-2.25%
Q1 Forecast
16.77

Adma Biologics reported $431.19M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Adma Biologics USD 431.19M 32.87M Sep/2025
Alnylam Pharmaceuticals USD 233.89M 16.7M Sep/2025
Dynavax Technologies USD 534.14M 39.98M Sep/2025
Takeda JPY 7.64T 513.39B Dec/2025